Lipella Pharmaceuticals Inc [LIPO] stock prices are down -3.48% to $3.88 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LIPO shares have gain 26.38% over the last week, with a monthly amount glided 29.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Lipella Pharmaceuticals Inc [LIPO] has been fluctuating between $2.21 and $12.00 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Lipella Pharmaceuticals Inc [NASDAQ: LIPO] shares were valued at $3.88 at the most recent close of the market. An investor can expect a potential drop of -48.45% based on the average LIPO price forecast.
Analyzing the LIPO fundamentals
The Lipella Pharmaceuticals Inc [NASDAQ:LIPO] reported sales of 0.48M for trailing twelve months, representing a drop of -22.75%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -10.58%, and Net Profit Margin reading is -17.43%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -1075.57 and Total Capital is -0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.67 points at the first support level, and at 3.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.12, and for the 2nd resistance point, it is at 4.35.
Ratios To Look Out For
It’s worth pointing out that Lipella Pharmaceuticals Inc [NASDAQ:LIPO]’s Current Ratio is 2.97. Further, the Quick Ratio stands at 2.97, while the Cash Ratio is 1.93. Considering the valuation of this stock, the price to sales ratio is 9.78, the price to book ratio is 2.90.
Transactions by insiders
Recent insider trading involved Kaufman Jonathan H, below., that happened on May 14 ’24 when 10000.0 shares were purchased. below., Kaufman Jonathan H completed a deal on Mar 18 ’24 to buy 30000.0 shares. Meanwhile, below. Kaufman Jonathan H bought 25000.0 shares on Mar 19 ’24.
